Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Clarus Therapeutics Hldgs Inc (CRXT)

Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clarus Therapeutics Hldgs Inc 555 SKOKIE BOULEVARD SUITE 340 NORTHBROOK IL 60062 USA

www.clarustherapeutics.com P: 847-562-4300

Description:

Clarus Therapeutics Inc. is a specialty pharmaceutical company which provide solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women. The Company's commercial product includes JATENZO(R). Clarus Therapeutics Inc., formerly known as Blue Water Acquisition Corp., is based in NORTHBROOK, Ill.

Key Statistics

Overview:

Market Capitalization, $K 2,471
Enterprise Value, $K -23,949
Shares Outstanding, K 52,021
Annual Sales, $ 13,960 K
Annual Net Income, $ -40,620 K
Last Quarter Sales, $ 4,050 K
Last Quarter Net Income, $ -10,690 K
60-Month Beta 1.96
% of Insider Shareholders 5.30%
% of Institutional Shareholders 9.26%
Float, K 49,264
% Float 94.70%
Short Volume Ratio 0.23

Growth:

1-Year Return -99.38%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 08/18/22
Next Earnings Date 08/22/22
Earnings Per Share ttm -1.79
EPS Growth vs. Prev Qtr 60.66%
EPS Growth vs. Prev Year -74.30%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRXT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -87.75%
Profit Margin % -290.97%
Debt/Equity 0.00
Price/Sales 0.26
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.25
Interest Coverage -1.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar